DanielRobertHelbigMD

Oncology • New York, NY

Internal Medicine Resident at NYP Weill Cornell

Join to view full profile

Dr. Helbig is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Helbig's full profile

Already have an account?

Office
505 E 70th St
# 505
New York, NY 10021
Phone+1 212-746-9663

Fax+1 212-746-3609

Education & Training

Albert Einstein College of MedicineClass of 2017

Certifications & Licensure

NJ State Medical License 2022 - 2025
PA State Medical License 2023 - 2024
NY State Medical License 2020 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

15 citations
Hispanic ethnicity is associated with younger age at presentation but worse survival in acute myeloid leukemia.
Karine Darbinyan, Aditi Shastri, Anjali Budhathoki, Daniel Helbig, Rose Snyder
Blood Advances. 2017-11-14
5 citations
Outcomes in CLL patients with NOTCH1 regulatory pathway mutations.
Daniel R. Helbig, Ghaith Abu-Zeinah, Erica B. Bhavsar, Paul J. Christos, Richard R. Furman
American Journal of Hematology. 2021-02-24

Lectures

Molecular Genetics and Prognosis in Younger Patients with Chronic Lymphocytic Leukemia (CLL)
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Outcomes in chronic lymphocytic leukemia (CLL) patients with NOTCH1 signaling pathway mutations.
2019 ASCO Annual Meeting - 6/1/2019